Decreased serum amyloid β1–42 autoantibody levels in...

Decreased serum amyloid β1–42 autoantibody levels in Alzheimer’s disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid β1–42 peptide

Sylvia Brettschneider, Nils G. Morgenthaler, Stefan J. Teipel, Christina Fischer-Schulz, Katharina Bürger, Richard Dodel, Yansheng Du, Hans-Jürgen Möller, Andreas Bergmann, Harald Hampel
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
57
Year:
2005
Language:
english
DOI:
10.1016/j.biopsych.2004.12.008
File:
PDF, 181 KB
english, 2005
Conversion to is in progress
Conversion to is failed